Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
| Status: | Terminated |
|---|---|
| Conditions: | Urology |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | 40 - Any |
| Updated: | 1/25/2019 |
| Start Date: | February 2016 |
| End Date: | December 2017 |
This randomized open-label study will be comprised of 2 cohorts: one control group and one
treatment group. The trial will be conducted as an open label randomized trial to evaluate
the efficacy of tamsulosin in the prevention of post-operative urinary retention. The study
will include pre- and post-surgical evaluations of patients including symptoms of urinary
retention and any adverse effects contributable to the study medication.
treatment group. The trial will be conducted as an open label randomized trial to evaluate
the efficacy of tamsulosin in the prevention of post-operative urinary retention. The study
will include pre- and post-surgical evaluations of patients including symptoms of urinary
retention and any adverse effects contributable to the study medication.
Inclusion Criteria:
- Any male age 40 or older
- Scheduled to undergo one of the planned surgeries (thoracic, general, or urologic)
- Ability to give informed consent
Exclusion Criteria:
- Current use of alpha blocker
- Current use of a strong CYP 3A4 inhibitors
- Any allergy to tamsulosin, alpha-blocker medication class, or anaphylaxis allergy to
sulfate containing medications
- Patients with any upcoming surgery for cataracts
- Currently enrolled in a clinical trial
- Inability to give informed consent
We found this trial at
1
site
60 Crittenden Blvd # 70
Rochester, New York 14642
Rochester, New York 14642
(585) 275-2121
Phone: 585-275-0998
University of Rochester The University of Rochester is one of the country's top-tier research universities....
Click here to add this to my saved trials
